Powered surgical instruments market seen reaching $3.33 billion by 2030

The powered surgical instruments market is projected to grow from $2.59 billion in 2026 to $3.33 billion by 2030, driven by more surgical procedures, minimally invasive operations and demand for cordless tools. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Powered surgical instruments sit at the center of surgery efficiency, precision and patient outcomes. - The market’s projected rise to $3.33 billion by 2030 signals continued spending on modern operating rooms, outpatient surgery capacity and advanced surgical tools. - Growth also reflects broader procedure volumes across orthopedic, neurosurgical and minimally invasive care.

What happened: - The Business Research Company said the global powered surgical instruments market is expected to rise from $2.45 billion in 2025 to $2.59 billion in 2026. - The firm projects the market will reach $3.33 billion by 2030, implying a 6.5% compound annual growth rate from 2026 to 2030. - The release was issued from London on August 25, 2026.

The details: - Powered surgical instruments are used for cutting, dissecting, drilling, sawing and suturing in a range of surgical procedures. - The company identified rising surgery volumes as a major driver of demand. - Market growth is also tied to expanding orthopedic and neurosurgical interventions. - Wider acceptance of powered surgical tools is supporting adoption across healthcare facilities. - Better availability of advanced surgical equipment and more hospital infrastructure are adding to near-term growth. - Future growth factors include more minimally invasive surgeries, heavier investment in modern operating rooms, rising demand for cordless surgical instruments, expanding outpatient procedures and a push to improve surgical efficiency. - Expected product trends include battery-operated tools, precision-controlled instruments, modular and multi-function platforms, and improved sterilization compatibility. - In June 2024, the American Society of Plastic Surgeons reported that liposuction was the most performed plastic surgery in 2023, with nearly 350,000 procedures, up 7% from 2022. - The same ASPS data showed hand surgeries rose 2% to 207,887 cases, while maxillofacial surgeries increased 1% to 52,868. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow fastest during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The forecast points to a market that is shifting toward portability, precision and workflow efficiency rather than basic device replacement. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as healthcare infrastructure expands. - Procedure growth data helps explain why surgical device makers are focusing on tools that can scale across more outpatient and minimally invasive cases.

What's next: - The market is likely to keep tracking surgical volume trends, operating-room modernization and adoption of cordless and battery-powered devices. - Product competition will probably center on precision, sterilization compatibility and multi-function design. - The firm is offering a free sample of the report and the full market report through its website.